Low-osmolar nonionic contrast agents pose a minimal safety risk to pediatric patients.
Low-osmolar nonionic contrast agents pose a minimal safety risk to pediatric patients.
Dr. Richard H. Cohan, a professor of radiology at the University of Michigan, and colleagues investigated the incidence of allergic-like reactions caused by low-osmolar nonionic contrast material in children from January 1999 through September 2004. They evaluated data from 11,306 patients who received contrast injections mostly for CT and for a few excretory urography exams. Fewer than 2% of the patients had severe but nonlethal acute allergic reactions related to contrast agents (AJR 2007;188:1643-1647).
Conventional wisdom holds that nonionic contrast agents pose minimal risk, but a sharp increase in the number of pediatric imaging exams using contrast media required a fresh look, Cohan said.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
Study Finds High Concordance Between AI and Radiologists for Cervical Spine Fractures on CT
May 6th 2024Researchers found a 98.3 percent concordance between attending radiology reports and AI assessments for possible cervical spine fractures on CT, according to new research presented at the 2024 ARRS Annual Meeting.